Bone marrow reinvestigation leading to the diagnosis of VEXAS syndrome.

UBA1 VEXAS syndrome vacuolization

Journal

Laboratory medicine
ISSN: 1943-7730
Titre abrégé: Lab Med
Pays: England
ID NLM: 0250641

Informations de publication

Date de publication:
26 Mar 2024
Historique:
medline: 26 3 2024
pubmed: 26 3 2024
entrez: 26 3 2024
Statut: aheadofprint

Résumé

A 46-year-old male patient presented with inflammatory diseases over more than 3 years. The patient suffered from recurrent pleuritis, polychondritis, orbital phlegmon, fever, and skin lesions. A bone marrow puncture added myelodysplastic syndrome to the patient's history. A focused cytomorphological reinvestigation of the archived bone marrow aspirate smears detected significant vacuolization of erythroid and myeloid precursor cells. Target sequencing revealed the UBA1 (p.Met41Thr) hotspot mutation that established the diagnosis of VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome.

Identifiants

pubmed: 38530637
pii: 7635085
doi: 10.1093/labmed/lmae020
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Bernhard Strasser (B)

Institute of Clinical Chemistry and Laboratory Medicine, Klinikum Wels-Grieskirchen, Wels, Austria.

Wolfgang Kranewitter (W)

Department of Internal Medicine I, Klinikum Wels-Grieskirchen, Wels, Austria.

Harald Hofer (H)

Department of Internal Medicine I, Klinikum Wels-Grieskirchen, Wels, Austria.

Alexander Haushofer (A)

Institute of Clinical Chemistry and Laboratory Medicine, Klinikum Wels-Grieskirchen, Wels, Austria.

Classifications MeSH